medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2020, Number 2

<< Back Next >>

Rev Mex Urol 2020; 80 (2)

Incidence and clinical characteristics of patients with genitourinary tuberculosis from 2003 to 2019 at a tertiary care hospital center

Gallegos-Sánchez G, Rosales-Velázquez CE, Ruvalcaba-Oceguera GE, Aragón-Castro MA, Gutiérre-Rosales R, Ordoñez-Jurado AU

Language: Spanish
References: 18
Page: 1-16
PDF size: 206.46 Kb.


ABSTRACT

Objective: To evaluate the incidence, clinical characteristics, and treatment of genitourinary tuberculosis (GUTB) in adult patients at our hospital, within the time frame of 2003-2019.
Design and methodology: A retrospective study was conducted on 18 patients (11 men and 7 women). The inclusion criteria were patients ›18 years of age with GUTB (ICD- 10-CM Diagnosis Code A18.1) that were hospitalized and treated at the Centro Médico ISSEMyM Toluca, within the period of January 2003 to December 2019.
Results: Renal tuberculosis was found in 7 patients and bladder tuberculosis in 3. Testicular, prostate, and ovarian tuberculosis were each found in 2 patients, one case presented with ureteral tuberculosis, and one case with adrenal gland tuberculosis. Mean patient age was 44.1 years (range: 23-79 years). Men accounted for 61.1% of the patients and women, 38.9%. Mean time from symptom onset to clinical diagnosis was ≥12 months (50%). Signs and symptoms: fever (61.1%), hematuria (55.6%), weakness (44.4%), lumbar pain (38.9%), weight loss (38.9%), and irritative symptoms of the urinary tract (33.3%). Diagnoses were confirmed through bacteriologic (55%), histopathologic (83%), and molecular (11%) methods. Urologic or gynecologic intervention was required in 100% of the patients. The standard 4-drug treatment was the preferred regimen (88.9%) and mean treatment duration was 11 ± 2 months. There were no posttreatment-related deaths.
Limitations: A retrospective study with a small number of patients.
Originality or value: To know the epidemiology of GUTB at our hospital center to improve the evaluation approach to patients and make opportune diagnoses, in an effort to reduce morbidity and mortality.
Conclusions: The early approach to GUTB is extremely important for ruling it out, treating it opportunely, and reducing permanent damage and death as much as possible.


REFERENCES

  1. Toccaceli S, Stella LP, Diana M, Taccone A, Giuliani G, De Paola L, et al. Renal tuberculosis: a case report. G Chir. 2015 27;36(2):76–8.

  2. Almazán-Treviño L, Reyes-Gutiérrez MA, Monjarás-Guerra. JI, Rodriguez-Robles JA, Hernández-González MM, Rosas-Nava JE. Tuberculosis primaria de la próstata. Reporte de un caso. Rev Mex Urol. 2016;76(4):245–9. doi: 10.1016/j.uromx.2016.02.008

  3. Daher EDF, Junior GB da S, Barros EJG. Renal Tuberculosis in the Modern Era. The American Journal of Tropical Medicine and Hygiene. 2013;88(1):54–64. doi: 10.4269/ ajtmh.2013.12-0413

  4. Salud S de. Programa de Acción Específico Prevención y Control de la Tuberculosis 2013- 2018. gob.mx. [accessed 11 Mar 2020] Available from: http://www.gob.mx/salud/documentos/ programa-de-accion-especifico-prevencion-ycontrol- de-la-tuberculosis-2013-2018

  5. Organización Panamericana de la Salud. Plan regional de tuberculosis 2006-2015. OPS Washington DC; 2006.

  6. Altiparmak MR, Trabulus S, Balkan II, Yalin SF, Denizli N, Aslan G, et al. Urinary tuberculosis: a cohort of 79 adult cases. Ren Fail. 2015;37(7):1157–63. doi: 10.3109/0886022X.2015.1057460

  7. Lee JY, Park HY, Park SY, Lee SW, Moon HS, Kim YT, et al. Clinical Characteristics of Genitourinary Tuberculosis during a Recent 10-Year Period in One Center. Korean J Urol. 2011;52(3):200–5. doi: 10.4111/ kju.2011.52.3.200

  8. Merchant S, Bharati A, Merchant N. Tuberculosis of the genitourinary system- Urinary tract tuberculosis: Renal Tuberculosis- Part I. Indian J Radiol Imaging. 2013;23(1):46– 63. doi: 10.4103/0971-3026.113615

  9. Wang J, Fan S, Xiao J, Liang C-Z. Renal tuberculosis tends to be low symptoms: how to improve the diagnosis and treatment of renal tuberculosis. Asian J Androl. 2016;18(1):145–6. doi: 10.4103/1008-682X.150839

  10. Abbara A, Davidson RN, Medscape. Etiology and management of genitourinary tuberculosis. Nat Rev Urol. 2011;8(12):678–88. doi: 10.1038/ nrurol.2011.172

  11. Kulchavenya E, Naber K, Bjerklund Johansen TE. Urogenital Tuberculosis: Classification, Diagnosis, and Treatment. European Urology Supplements. 2016;15(4):112–21. doi: 10.1016/j.eursup.2016.04.001

  12. Kulchavenya E. Best practice in the diagnosis and management of urogenital tuberculosis. Ther Adv Urol. 2013;5(3):143–51. doi: 10.1177/1756287213476128

  13. Figueiredo AA, Lucon AM, Srougi M. Urogenital Tuberculosis. Microbiol Spectr. 2017;5(1). doi: 10.1128/microbiolspec.TNMI7-0015-2016

  14. Collura-Merlier S, Ramírez-Bonilla M, Ochoa-López JM, Herrera-Cáceres O, Reyes- Utrera C, Sandoval-Barba H, et al. Carcinoma renal de células claras localmente avanzado con tuberculosis renal asociada. Rev Mex Urol. 2015;75(5):297–300. doi: 10.1016/j. uromx.2015.06.010

  15. Kulchavenya E. Urogenital tuberculosis: definition and classification. Ther Adv Infect Dis. 2014;2(5–6):117–22. doi: 10.1177/2049936115572064

  16. Jagodziński J, Zielonka TM, Peplińska K, Życińska K. Tuberculosis of the Urogenital Tract in Adults in a Tertiary Referral Center. Adv Exp Med Biol. 2018; 1040:29–37. doi: 10.1007/5584_2017_103

  17. Yadav S, Singh P, Hemal A, Kumar R. Genital tuberculosis: current status of diagnosis and management. Transl Androl Urol. 2017;6(2):222–33. doi: 10.21037/ tau.2016.12.04

  18. Wejse C. Medical treatment for urogenital tuberculosis (UGTB). GMS Infect Dis. 2018;6: Doc04. doi: 10.3205/id000039




2020     |     www.medigraphic.com